Teishima J, Hara T, Tobe T, Hirata J, Ueki H, Wakita N, et al. Therapeutic outcome of combination therapy using immune-checkpoint inhibitors and tyrosine kinase inhibitors for metastatic non-clear-cell renal cell carcinoma . CUAJ [Internet]. 2024 Jan. 30 [cited 2026 May 20];18(5):E162-6. Available from: https://cuaj.ca/index.php/journal/article/view/8548